These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11983534)

  • 1. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
    Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
    Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity.
    Mayur YC; Padma T; Parimala BH; Chandramouli KH; Jagadeesh S; Gowda NM; Thimmaiah KN
    Med Chem; 2006 Jan; 2(1):63-77. PubMed ID: 16787357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel bisacridone and comparison with PSC 833 as a potent and poorly reversible modulator of P-glycoprotein.
    Horton JK; Thimmaiah KN; Altenberg GA; Castro AF; Germain GS; Gowda GK; Houghton PJ
    Mol Pharmacol; 1997 Dec; 52(6):948-57. PubMed ID: 9415704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
    Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
    Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells.
    Thimmaiah KN; Horton JK; Seshadri R; Israel M; Houghton JA; Harwood FC; Houghton PJ
    J Med Chem; 1992 Sep; 35(18):3358-64. PubMed ID: 1527786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells.
    Hegde R; Thimmaiah P; Yerigeri MC; Krishnegowda G; Thimmaiah KN; Houghton PJ
    Eur J Med Chem; 2004 Feb; 39(2):161-77. PubMed ID: 14987825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines.
    Thimmaiah KN; Horton JK; Qian XD; Beck WT; Houghton JA; Houghton PJ
    Cancer Commun; 1990; 2(7):249-59. PubMed ID: 2378785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Hill BT; Hosking LK
    Cancer Chemother Pharmacol; 1994; 33(4):317-24. PubMed ID: 8281626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
    Murahari M; Kharkar PS; Lonikar N; Mayur YC
    Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M; Morris MB; Roufogalis BD
    Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines.
    Mohana S; Ganesan M; Rajendra Prasad N; Ananthakrishnan D; Velmurugan D
    BMC Cancer; 2018 Nov; 18(1):1168. PubMed ID: 30477461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring.
    Lee Y; Yeo H; Liu SH; Jiang Z; Savizky RM; Austin DJ; Cheng YC
    J Med Chem; 2004 Oct; 47(22):5555-66. PubMed ID: 15481991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.